PDCD1 and Miyoshi myopathy: Increased expression of LAG3 on T cells in the tumor milieu of MM has been noted in murine models and there is preclinical evidence of synergy between PD-1 and LAG3 inhibition, which could represent an important dual immune targeting strategy15.